Last week saw the newest third-quarter earnings release from Neuronetics, Inc. (NASDAQ:STIM), an important milestone in the company's journey to build a stronger business. Neuronetics reported ...
MALVERN, Pa. and TORONTO, Oct. 4, 2024 /PRNewswire/ - Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today ...
(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker ...
Neuronetics, Inc., a medical technology company focused on mental health, has announced key updates regarding its NeuroStar therapy. The company will be a Silver Sponsor at the 13th Annual Clinical ...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Why Neuronetics is back on ...
Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of 25% ...
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing products ...
Neuronetics has secured a groundbreaking green light for its noninvasive transcranial magnetic stimulation technology, saying it is now the first to be cleared by the FDA as an add-on therapy for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Neuronetics, which has 203 ...
Completed secondary offering of 9,200,000 shares of our common stock raising approximately $18.9 million in net cash in February 2025 Fully executed actions to realize over $21 million of the targeted ...
We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Neuronetics Inc (NASDAQ:STIM) stands against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results